In-depth quantitative proteomics uncovers specie-specific metabolic programs in Leishmania (Viannia) species by Pinho, N. et al.
RESEARCH ARTICLE
In-depth quantitative proteomics uncovers
specie-specific metabolic programs in
Leishmania (Viannia) species
Nathalia PinhoID1, Jacek R. Wiśniewski2, Geovane Dias-LopesID3, Leonardo Saboia-
VahiaID1¤a, Ana Cristina Souza Bombac¸aID4, Camila Mesquita-Rodrigues4, Rubem Menna-
BarretoID4, Elisa Cupolillo1, Jose Batista de Jesus3,5, Gabriel Padro´nID1¤b,
Patricia CuervoID1*
1 Laborato´rio de Pesquisa em Leishmanioses, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, RJ, Brazil,
2 Biochemical Proteomics Group, Department of Proteomics and Signal Transduction, Max-Planck-Institute
of Biochemistry, Martinsried, Germany, 3 Laborato´rio de Biologia Molecular e Doenc¸as Endêmicas, Instituto
Oswaldo Cruz, Fiocruz, Rio de Janeiro, RJ, Brazil, 4 Laborato´rio de Biologia Celular, Instituto Oswaldo Cruz,
Fiocruz, Rio de Janeiro, RJ, Brazil, 5 Departamento de Medicina–Universidade Federal de São João Del Rei,
Campus Dom Bosco, São João del Rei, MG, Brazil
¤a Current address: Laborato´rio Parasitologia Celular e Molecular, Instituto Rene´ Rachou, Fiocruz, Belo
Horizonte, MG, Brazil
¤b Current address: Center for Genetic Engineering & Biotechnology, La Habana, Cuba
* patricia.cuervo@fiocruz.br
Abstract
Leishmania species are responsible for a broad spectrum of diseases, denominated Leish-
maniasis, affecting over 12 million people worldwide. During the last decade, there have
been impressive efforts for sequencing the genome of most of the pathogenic Leishmania
spp. as well as hundreds of strains, but large-scale proteomics analyses did not follow these
achievements and the Leishmania proteome remained mostly uncharacterized. Here, we
report a comprehensive comparative study of the proteomes of strains representing L. brazi-
liensis, L. panamensis and L. guyanensis species. Proteins extracted by SDS-mediated
lysis were processed following the multi-enzyme digestion-filter aided sample preparation
(FASP) procedure and analysed by high accuracy mass spectrometry. “Total Protein
Approach” and “Proteomic Ruler” were applied for absolute quantification of proteins. Princi-
pal component analysis demonstrated very high reproducibility among biological replicates
and a very clear differentiation of the three species. Our dataset comprises near 7000 pro-
teins, representing the most complete Leishmania proteome yet known, and provides a
comprehensive quantitative picture of the proteomes of the three species in terms of protein
concentration and copy numbers. Analysis of the abundance of proteins from the major
energy metabolic processes allow us to highlight remarkably differences among the species
and suggest that these parasites depend on distinct energy substrates to obtain ATP.
Whereas L. braziliensis relies the more on glycolysis, L. panamensis and L. guyanensis
seem to depend mainly on mitochondrial respiration. These results were confirmed by bio-
chemical assays showing opposite profiles for glucose uptake and O2 consumption in these
species. In addition, we provide quantitative data about different membrane proteins, trans-
porters, and lipids, all of which contribute for significant species-specific differences and
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Author summary
Leishmania braziliensis, L. panamensis, and L. guyanensis are responsible for most of the
cases of tegumentary leishmaniasis (TL) in the Americas. These species are associated
with a variety of clinical manifestations of TL ranging from self-healing localized cutane-
ous lesions to disseminated and mucocutaneous presentations that may result in severe
oropharyngeal mutilation. Here, we report a comprehensive quantitative comparison of
the proteome of those species. Assessment of absolute titers of ~7000 proteins revealed a
very clear differentiation among them. Significant differences in energy metabolism,
membrane proteins, transporters, and lipids are contributing for species-specific traits
and provide rich substrate for exploring new molecules for diagnosing purposes.
Introduction
Leishmania species are responsible for a broad spectrum of diseases denominated Leishmania-
sis that affects over 12 million people worldwide [1]. Leishmania braziliensis, L. panamensis,
and L. guyanensis are species of the Leishmania (Viannia) subgenus that comprises exclusively
Neotropical parasites currently distributed across the American continent. These species are
responsible for most of the cases of localized cutaneous leishmaniasis (LCL) in the Americas,
but are also associated with the mucocutaneous form of the disease [1]. Mucocutaneous leish-
maniasis (MCL) results from the parasite metastasis to the oropharyngeal mucosal tissues via
lymphatic or haematogenous dissemination. In advanced stages, MCL may result in severe
mutilation by destruction of the palate and nose cartilage [2]. Moreover, whereas L. panamen-
sis is mainly associated to LCL, L. braziliensis may cause multiple disseminated cutaneous
lesions, frequently refractory to treatment [1,3]. In addition, in some regions L. guyanensis is
frequently isolated from patients who failed to response to pentavalent antimonial (SbV), the
first line treatment for dermal leishmaniasis [4]. Despite that severity, currently there are no
prognostic tools for the prediction of the clinical outcome after infection with those species,
neither proper species-specific diagnostic tools that may orientate the therapeutic decision.
Heterogeneous clinical manifestations are the result of a complex interaction among host
immune responses, host genetic background and parasite characteristics such as virulence,
infectivity and pathogenicity [5]. Among others, to understand the parasite contribution for
the clinical outcome, complete genome sequences of most of the pathogenic Leishmania spe-
cies and hundreds of strains have been obtained [6–17], paving the way for the analyses of
their proteomes. However, such a massive effort has not been followed by proteomics studies.
The first more comprehensive proteomics identification of a Leishmania species was
accomplished using gel-free analysis of L. donovani and L. mexicana, with up to ~1800 pro-
teins identified, representing ~20% of the Leishmania predicted proteome [18,19]. In addition,
protein abundance was estimated for the proteins identified in the L. mexicana dataset by cal-
culating the exponentially modified protein abundance index (emPAI) [19]. Recently, proteo-
genomic re-analysis of L. donovani proteome identified ~4000 unique proteins [20]; studies
on the L. mexicana flagellar proteome identified ~2800 proteins, among which, 701 composed
the flagellar proteome [21]; subcellular multi-step fractionation of L. donovani allowed
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identification of ~3900 proteins, included 645 integral membrane proteins [22]. Despite those
important achievements, no Leishmania proteome has been described in large-scale nor deep
quantitative data is available.
Seminal works on L. (Viannia) proteomes used 2DE of cell lysates with the aim to differenti-
ate distinct Leishmania species causing American tegumentary leishmaniasis [23]. Since that,
advances in MS protein identification driven the first proteomic maps of L. braziliensis, L. pana-
mensis and L. guyanensis [24–35]. Using different methods for sample preparation, up to some
hundreds of proteins were identified in these species. Regardless these efforts, identification and
quantitative organization of the L. (Viannia) species proteome remains mostly uncharacterized.
Despite the advances in mass spectrometry instrumentation, the quality of the sample prep-
aration still determines the quality and depth of the proteomic analysis. The combination of
SDS as denaturant for efficient protein extraction, followed by depletion of the detergent by
successive washes with concentrated urea in a filter device and consecutive digestion with
LysC and trypsin has proven to be an efficient method for sample preparation [31–33].
Here, we describe a comprehensive quantitative analysis of the proteome of three strains
that represent distinct and clinically/epidemiologically relevant species of L. (Viannia) subge-
nus: L. braziliensis (strain MHOM/BR/2000/LTCP 13396), L. panamensis (strain MHOM/CO/
2009/6634) and L. guyanensis (strain MHOM/BR/1997/NMT-MAO 292P). We combined the
filter-aided sample preparation (FASP) method with the consecutive multi-enzyme digestion
[31,32] followed by high accuracy mass spectrometry and the “Total Protein Approach” and
“Proteomic Ruler” [34,35] for calculation of absolute protein abundances in those species. Our
dataset comprises near 7000 proteins, representing the most complete Leishmania proteome
yet reported, and provides the first comprehensive quantitative analysis of the proteomes of
the three species in terms of protein concentration and copy numbers. We describe the basic
subcellular organization of the parasites and the cumulative abundance of proteins from the
major metabolic processes and demonstrate the main differences among those three species.
Methods
Parasite culture
Leishmania braziliensis (MHOM/BR/2000/LTCP 13396), L. panamensis (MHOM/CO/2009/
6634) and L. guyanensis (MHOM/BR/1997/NMT-MAO 292P) strains used in this study are
open deposits and were provided by the Collection of Leishmania of the Oswaldo Cruz Founda-
tion, CLIOC (http://clioc.fiocruz.br/). Through the text, tables and figures those strains will be
mentioned as L. braziliensis, L. panamensis and L. guyanensis. Parasites were grown in Schnei-
der’s medium containing 20% fetal bovine serum (heat inactivated at 56˚C for 50 min) at 25˚C.
Parasites were collected in the late logarithmic growth phase by centrifugation at 1800 x g for 5
min, and washed twice in PBS, pH 7.2. In order to obtain meaningful data, we analyzed para-
sites collected from five independent biological assays (five biological replicates) of each L. bra-
ziliensis and L. panamensis and four independent biological assays (four biological replicates) of
L. guyanensis. Variables such as the lots of culture medium and serum were controlled. Accord-
ing with the Brazilian Law of Biodiversity, this study was registered at SisGen (AA2236F).
Sample preparation
Parasites were lysed in a buffer containing 0.05 M Tris-HCl, pH 7.6, 0.05 M DTT and 2% SDS
in a boiling water bath for 5 min. After chilling to room temperature, the lysates were clarified
by centrifugation at 10,000×g for 5 min. Total protein was determined by BCA using a Nano-
drop instrument. Aliquots containing 100 μg total protein were processed by the MED-FASP
(Multi-Enzyme Digestion—Filter Aided Sample Preparation) method using consecutively
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LysC and trypsin [32,33]. Peptides were collected, concentrated and desalted on a C18 reverse
phase column.
Liquid Chromatography–Tandem Mass Spectrometry
The peptide mixtures were analysed using a Q-Exactive HF mass spectrometer (Thermo-Fisher
Scientific, Palo Alto). The chromatography was performed using 2 μg of total peptide on a 50 cm
column with 75μm inner diameter packed with 1.8 μm C18 particles (100 Å pore size; Dr. Maisch,
Ammerbuch-Entringen, Germany). Peptide separation was carried out using a 105 min acetoni-
trile gradient in 0.1% formic acid at a flow rate of 250 nl/min. The backpressure varied between
450 and 650 bar. The Q-Exactive HF mass spectrometer was operated in data-dependent mode
with survey scans acquired at a resolution of 50 000 at m/z 400 (transient time 256 ms). Up to the
top 15 most abundant isotope patterns with charge� +2 from the survey scan (300–1650 m/z)
were selected with an isolation window of 1.6 m/z and fragmented by HCD with normalized colli-
sion energies of 25. The maximum ion injection times for the survey scan and the MS/MS scans
were 20 and 60 ms, respectively. The ion target value for MS1 and MS2 scan modes was set to
3 × 106 and 1 × 105, respectively. The dynamic exclusion was 25 s and 10 ppm.
Proteomic data analysis
The data were analyzed with MaxQuant Software using the L. braziliensis protein sequences
available at UniProt database. The parameters of the search included a fragment ion mass tol-
erance of 0.5 Da and parent ion tolerance of 20 ppm. The maximum false peptide and protein
discovery rate was set as 1%. Cysteine carbamidomethylation was set as fixed modification,
methionine oxidation as variable modification, and a maximum of two missed cleavages was
allowed. Protein abundances were calculated based on the spectral protein intensity (raw
intensities) using the ‘Total Protein Approach’ (TPA) for absolute protein quantification and
the ‘Proteomic Ruler’ approach [35] for assessing the protein copy number per cell, total pro-
tein, protein concentration and copy number were calculated in Microsoft Excel. The Perseus
software (Ver. 1.6.5.0) [36] was used for statistical analysis. Minimal number of valid values
was set to 4 per protein, for at least one species, and missing values were imputed from a nor-
mal distribution. Significances were calculated using the t-test with a threshold of false discov-
ery rate (FDR) of 1%. The data are presented as the mean ± SD.
Enrichment analysis based on Gene Ontology and Metabolic Pathway
annotations
In order to analyze if there were particular groups of proteins that contributed the most for
distinguishing the L. (Viannia) species, only the proteins that presented simultaneously signifi-
cant differences in concentration among the three species were used for enrichment analysis
of gene ontology and metabolic pathway annotations using the enrichment tool at Tritrypdb
(http://tritrypdb.org, v46). Parameters were set as follows: organism, L. braziliensis MHOM/
BR/75/M2904 and p-value cutoff, 0.05.
Analysis of 2-NBDG uptake
Procyclic promastigotes of the late logarithmic growth phase (5×106 parasites/mL) were
washed (2000 x g for 10 min) and pre-incubated in 10 mM phosphate buffered saline (PBS, pH
7.2, Sigma-Aldrich, St. Louis, USA) for 30 min at 28˚ C. Then, the cells were incubated with
300 μM 2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)Amino)-2-Deoxyglucose (2-NBDG, Molec-
ular Probes, Massachusetts, USA), a fluorescent glucose analogue, for 30 min at 28˚ C. The
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2-NBDG specificity was monitored by the parasite incubation at 4˚C for 30 min, to decrease
the glucose uptake. After this time, the parasites were washed and resuspended in PBS and
2-NBDG+ promastigotes were analyzed using a CytekDxP Multi-Color Upgrades flow cytom-
eter (Cytek, Fremont, USA). A total of 10,000 events were acquired in the region previously
established to correspond to protozoa and analyses were performed in Summit 6.1 software
(Beckman Coulter, Brea, USA). Three biological replicates were analyzed. Student´s t test was
used for analyzing the statistical significance of the differences observed among species, values
of p< 0.05 were accepted and data are presented as the mean ± SD.
Analysis of oxygen uptake
Promastigotes (2.5 × 107 cells/mL) were resuspended in 2 mL of respiration buffer (125 mM
sucrose, 65 mM KCl, 10 mM Tris-HCl pH 7.2, 1 mM MgCl2, and 2.5 mM potassium phos-
phate monobasic) at 26˚C under continuous stirring and analyzed in a high-resolution oxy-
graph 2K (Oroboros Instruments, Innsbruck, Tyrol, Austria). Mitochondrial oxygen
consumption was confirmed by the addition of 2 μM antimycin A (AA) (Sigma-Aldrich,
St. Louis, Missouri, USA) to reach residual oxygen consumption (ROX). Oxygen concentra-
tion and flux were acquired and analyzed using the DatLab software. Statistical significance
was assessed by Student´s t test and results are shown as the mean ± SD of three independent
experiments (three biological replicates).
Gene expression analysis
Gene expression levels were analyzed by qPCR for 10 genes encoding for proteins that pre-
sented statistical differences of abundance among at least two species. Oligonucleotide
sequences of the target and reference genes (S1 Table) were designed using the Primer-BLAST
designing tool from available public sequences for L. braziliensis. Total RNA was extracted
from cells by using Trizol Reagent according to the manufacturer’s instruction. The quantity
and integrity of RNA were determined by spectrophotometer (Nanodrop ND-1000, Nano-
Drop Technologies); cDNA was synthesized from 2 μg of total RNA using SuperScript III
reverse transcription system and oligo-dT primers in total reaction volumes of 20 μL. Real-
time PCR was carried out in duplicate using SYBR Green PCR Master Mix (Applied Biossys-
tems) and the Vii7 Sequence Detection System (Applied Biossystems), following the manufac-
turer’s procedures. PCR conditions for all primers were optimized and specificities were
verified by melting curve analyses and agarose gel electrophoresis. The cDNAs were amplified
during 40 cycles consisting of 10 s of denaturation at 95˚C, 20 s of annealing at 56˚C, and 20 s
of extension at 72˚C. Gene expression was quantified by means of the comparative Ct method
(ΔΔCt). The linearity of the assay was evaluated using a standard curve for each gene from
serial dilutions of pooled cDNAs from all samples. The efficiency of amplification for each
gene was calculated from the standard curve of each gene. Data are shown as normalized ratios
between target gene expression and geometric media of the reference genes. Three indepen-
dent assays were performed following the MIQE guidelines [37].
Results and discussion
The Leishmania (Viannia) proteome is distributed in about six orders of
magnitude and L. braziliensis, L. panamensis and L. guyanensis are clearly
separated by differences in their protein concentrations
To obtain an in-depth quantitative description of the L. (Viannia) proteome, whole cell lysates,
of four-five independent biological replicates, from each of the species were processed by
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MED-FASP and analyzed by LC-MS/MS. Searches with MaxQuant software resulted in the
identification of 120224 peptides corresponding to 6930 proteins, of which 95% (6530) were
identified with at least three peptides and 80% (5544) with at least six peptides (S1 Fig, S2
Table). Our dataset comprises ~85% of the Leishmania predicted proteome (~8000 protein-
coding genes predicted, considering one protein per gene) [6,7,9,12] and therefore represents
the most complete proteome for a Leishmania species yet described. More than 3000 proteins
were identified for the first time (S2 Table). Pearson’s correlation analysis revealed high repro-
ducibility of proteomics data between biological replicates (coefficient > 94%) (S1 Fig). More
than 6600 proteins were identified in each replicate and 6033 proteins were identified in all 14
samples (S3 Table).
Analysis of the data showed that only 9% of identified proteins have Gene Ontology annota-
tions for cellular component, molecular function and biological process together (S2 Fig).
Considering only the ontological annotation for cellular component we found that about 4900
proteins in our data set appear as uncharacterized. Despite efforts for improving L. braziliensis
annotations [38], functional annotation of Leishmania spp. is still very limited and represents a
bottleneck in the biological interpretation of transcriptomics and proteomics data.
After statistical analysis using Perseus, a total of 6821 proteins were statistically validated in
at least 10 out of the 14 samples (FDR 1%) and these were used for estimation of total protein
contents, protein concentrations and protein copy numbers using the total protein approach
(TPA) and the histone ruler methods. Principal component analysis (PCA) of the protein con-
centrations showed tight clustering for each set of biological replicates and revealed a clear sep-
aration among the strains representing L. braziliensis, L. panamensis and L. guyanensis
samples (Fig 1A). Although proteomes are highly dynamic and may vary according to parasite
stage, culture conditions and probably to intra-specific diversity of Leishmania, our results
show that global protein abundances obtained by deep proteomics are able to clearly distin-
guish the three species, in a similar way that deep genome sequencing allows such distinction
[9,12].
The total protein contents per cell were calculated using the histone ruler method based on
the genome data for L. braziliensis, L. panamensis and L. guyanensis (strains M2904, PSC-1
and CL085, respectively) and that report 32Mb, 30Mb and 31Mb DNA, respectively [6,9,12].
These values correspond to 0.035 pg, 0.033 pg and 0.034 pg of DNA, respectively, per haploid
genome. Assuming diploidy, L. braziliensis, L. panamensis and L. guyanensis strains used in
this study contain 3.86 ± 0.1 pg, 3.89 ± 0.08 pg and 3.55 ± 0.2 pg of total protein per cell,
respectively (Fig 1B, Table 1). These values are similar to the protein estimation reported by
Aebischer [39] for L. mexicana, which corresponds to ~4 pg. Although we are aware that these
calculations could vary according to the ploidy of the genome, the ploidy status of the strains
here studied is unknown. Because it has been shown that the chromosome number in Leish-
mania sp. (i) varies among species and strains [7,8,12,13]; (ii) varies in response to external sti-
muli [13,15,16, 40,41]; (iii) is present as a mosaic, i.e., different chromosomes have different
ploidy [42]; (iv) is highly variable in vitro-cultivated strains but does not seem to vary as much
in intracellular parasites from mammal hosts [17,41], and (v) has been barely studied in species
of the subgenus L. (Viannia), we opted for a parsimonious assumption of a diploid state for
the three species here studied. Nevertheless, the power of the quantitative method used here
can at any time revisit the calculations and adjust the protein concentrations according to the
observed ploidy for each chromosome in each species, since it does not depend on chemical
markers or external standards.
Using the values of total protein contents, we calculated protein copy numbers per species
and estimated the total protein molecules per parasite to be 6.4 ± 0.20 x 107 for L. braziliensis,
6.3 ± 0.13 x 107 for L. panamensis, and 5.9 ± 0.35 x 107 for L. guyanensis (Table 1). The protein
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Fig 1. Description of the Leishmania (Viannia) proteomes. Whole cell lysates from L. braziliensis, L. panamensis and L. guyanensis were processed by
MED-FASP and analyzed by LC-MS/MS. Protein abundances were calculated based on the raw spectral intensities. (A) Principal component analysis of the
protein concentration values of all identified proteins determined by the Total Protein Approach, (TPA), method. The close clustering of each set of biological
replicates reveals accurate reproducibility among independent biological samples. (B) Total protein content per cell, n = 5 biological replicates for L. braziliensis
and L. panamensis and n = 4 for L. guyanensis. Values are expressed in pg ± SD. (C) Dynamic range of protein copy numbers across all proteins identified in each
species. Protein abundances were ranked from the highest to the lowest copy number in the Leishmania samples. (D) Venn plot with number of proteins
identified in each species.
https://doi.org/10.1371/journal.pntd.0008509.g001
Table 1. Summary of general information about the proteomes of Leishmania braziliensis, L. panamensis and L. guyanensis promastigotes.
L. braziliensis L. panamensis L. guyanensis
International code MHOM/BR/2000/LTCP 13396 MHOM/CO/2009/6634 MHOM/BR/1997/NMT-MAO 292P
Biological replicates 5 5 4
Peptides identified 78398 77940 62018
Protein groups identified 6779 6783 6764
Total protein per cell 3.86 ± 0.1 pg 3.89 ± 0.08 pg 3.55 ± 0.2 pg
Total protein molecules per parasite 6.4 ± 0.20 x 107 6.3 ± 0.13 x 107 5.9 ± 0.35 x 107
https://doi.org/10.1371/journal.pntd.0008509.t001
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copy number values span 6 orders of magnitude (Fig 1C). A total of 6779 proteins were identi-
fied in L. braziliensis, 6783 in L. panamensis and 6764 in L. guyanensis. A total of 6708 proteins
were identified as common to the three species (Fig 1D).
Among the top 20 most abundant proteins we found histones H3, H4, H2B, alpha- and
beta-tubulin, elongation factor 1-alpha, HSP70 and HSP83, among others, with an estimated
mean among the three species around 750000, 580000, 680000, 560000, 545000, 530000,
400000, 300000 copies per cell, respectively (Table 2). These proteins are in fact the most abun-
dant in the proteomes of other Leishmania species, [43,44] and, probably for this reason, they
are frequently identified in proteomic studies independently of the phenomenon studied.
Interestingly, those proteins are coded by gene arrays with more than 10 gene copies each one
[7,9,12], suggesting a correlation between gene copy number and protein copy number, at
least for those genes, in the strains of L. (Viannia) species studied here. Among other highly
abundant molecules were various ribosomal proteins including several 40S and 60S subunits
involved in translation of mRNA. Such molecules were also identified among the top 30 most
highly expressed genes in different isolates of L. tropica [11]. However, some of the most abun-
dant gene arrays reported to date in L. braziliensis, L. panamensis and L. guyanensis, such as
amastin-like surface protein, TATE DNA transposon, GP63, folate/biopterin transporter and
tuzin [7,9,12], were not among the most abundant proteins (top 20, Table 2, or even top 100,
S2 Table) in our dataset, evidencing that for those proteins there is a poor correlation between
gene and protein copy numbers. Nevertheless, such lack of correlation could be associated,
among others, with the parasite stage, i.e., some gene arrays are more recruited during
Table 2. Top 20 most abundant protein groups in Leishmania (Viannia) proteomes in terms of protein copy number. Protein IDs according to UniProt. Detailed
information in S2 Table. Lb: L. braziliensis; Lp: L. panamensis; Lg: L. guyanensis.
Majority
protein ID










A4H675 Histone H3 1 19 14.76 683514 781749 797009
A4H7X1 Histone H4 5 17 11.36 632678 518407 591973
A4H9W2 Histone H2B 2 16 12.40 615245 701910 721757
A4HLC9 Tubulin beta chain 4 38 49.76 596408 564945 516207
A4H727 Tubulin alpha chain 3 52 49.68 566849 561107 507227
A4H8V4 Elongation factor 1-alpha 1 51 49.07 550167 489947 554094
A4HBV1 Histone H2A 3 16 14.13 520962 354314 320116
A4HMP3 Kinetoplastid membrane protein-11 1 17 11.17 501495 545944 420273
A4HER9 Putative 10 kDa heat shock protein 1 12 10.75 477486 294995 301477
A4HGY1 Putative heat-shock protein hsp70 3 70 71.28 429433 353265 400574
A4H5R9 Putative calmodulin 1 17 16.82 392799 434208 399249
A4HGV8 Putative 40S ribosomal protein S17 1 21 16.56 350644 286853 297001
A4H7N9 Putative calpain-like cysteine
peptidase
1 15 13.06 339950 295024 232822
A4HKT8 Nucleoside diphosphate kinase (EC
2.7.4.6)
2 16 16.69 336687 301436 167969
A4HL70 Heat shock protein 83–1 1 80 80.66 327133 281794 260786
A4H8H2 Putative 60S ribosomal protein L21 2 24 18.03 326347 292275 307616
A4HD62 Putative 60S ribosomal protein L17 1 15 19.01 316904 296723 301417
A4HMZ5 Putative 60S ribosomal subunit
protein L31
1 21 21.38 301492 254432 243122
A4HAF8 Contig, possible fusion of
chromosomes 20 and 34
1 12 13.07 299331 231468 250427
A4HGE0 40S ribosomal protein S14 1 15 15.67 294401 248622 256815
https://doi.org/10.1371/journal.pntd.0008509.t002
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procyclic or metacyclic promastigote stage whereas others should be preferentially recruited
during amastigote stage. Indeed, it has been shown that amastin is preferentially expressed by
amastigotes during the interaction with macrophages [45]. On the other hand, deep proteome
data as that obtained here allowed us to detect, identify and quantify low abundant proteins
such as a protein kinase (A4HLK1), a subtilisin-like serine peptidase (A4H792) and a lot of
uncharacterized proteins (ex: A4HM75, A4HP44 and A4H8S3), all of them presenting around
50–80 copies per cell (S2 Table). Interestingly, the quantitative data here provided may impact
the selection of vaccine candidate antigens. Indeed, because protein abundance will determine
its chance to be processed and loaded onto MHC molecules, it has been proposed that protein
abundance is the single most important parameter to take into account when a vaccine candi-
date antigen is being selected [39].
The protein copy number has low correlation with the protein molecular
weight
We analyzed the correlation of the protein abundance in terms of copy number, using the
mean value obtained for the three species, against the molecular weight of the identified pro-
teins. Although, in general, smaller proteins present more copies than larger proteins, we
observed that there is a low correlation between the number of molecules per protein and the
molecular weight (R2 = 0.129) (Fig 2A). For example, the putative calpain-like cysteine pepti-
dase (A4HFH6) with 701.07 kDa, one of the largest proteins in our proteome dataset, pre-
sented approximately 29400 copies, representing ~0.05% of total parasite protein mass, in
contrast to smaller putative calpain-like cysteine peptidases (A4HJ22 and A4HJ21) with
around 100 kDa that presented 200–600 copies per cell. Our data agree with previous reports
on Saccharomyces cerevisiae and Escherichia coli protein abundance that found moderate or no
correlation between protein size and protein abundance [46,47].
We also analyzed the protein abundance of basic components of promastigotes architecture
and metabolism, in terms of percentage of total cellular protein or copy number. Based on the
current gene ontology annotations of cellular component, ribosome subunits compose ~12%
of the total protein mass (Fig 2B), whereas membrane, mitochondrion, flagellum and nucleus
proteins compose ~5.7, 5.3, 3.8, and 4.1% of the proteome, respectively (Fig 2B). The abun-
dance of ribosomal subunits in our dataset is in agreement with the high activity of translation
and synthesis of proteins observed in organisms in the logarithmic growth phase, such as the
parasites used here (S3 Fig). In our dataset, ribosomal proteins of the large and small subunits
consist of 64 and 36 proteins respectively. In agreement with the 1:1 stoichiometry, the average
copy numbers of those proteins were 1.3 ± 0.06 × 105 and 1.5 ± 0.09 × 105, for the large and
small subunits, respectively (Fig 2C).
Energy metabolism molecules comprise about 8% of all molecules per cell
Quantitative proteomic data allowed us to determine the abundances of proteins involved in
the main metabolic processes for energy production in those parasites. In our dataset, both gly-
cosomal and cytosolic glycolytic enzymes were detected and quantified, representing near 1.2
million molecules per cell (Fig 2D, S2 Table). In addition, oxidative phosphorylation enzymes
were represented by near 1.1 million molecules per cell. It is known that generation of ATP in
promastigotes involves mainly glycolysis and oxidative phosphorylation [48]. In agreement,
our dataset reveled that abundance of the proteins involved in those metabolic processes repre-
sents 3.7% of all protein molecules per cell. We also observed an important contribution of
enzymes from other processes involved in ATP generation such as tricarboxylic acid cycle
with an estimate of ~1.0 million molecules per cell, as well as amino acid oxidation and fatty
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acid beta-oxidation, comprising an estimate of 860.000, and 410.000 molecules per cell, respec-
tively (Fig 2D). Together, all those energy metabolic processes comprise ~ 4.6 million of mole-
cules per cell, which corresponds to about 7.4% of all molecules per promastigote (Fig 2D, S2
Table).
Leishmania braziliensis, L. panamensis and L. guyanensis exhibit significant
differences in protein abundance
Statistical significance of differences in protein abundance among the species was determined
by t-test analyses. In total, at FDR of 1%, the concentrations of 2112 proteins were significantly
different between L. braziliensis and L. panamensis, 1639 between L. braziliensis and L. guya-
nensis and 1089 between L. panamensis and L. guyanensis (Fig 3A, S4 Table). Remarkably, the
concentration of 185 proteins was different across the three species (Fig 3A), and near 45% of
Fig 2. Quantitative analysis of the proteomes of Leishmania (Viannia) species. (A) Correlation between protein copy numbers and molecular weight, R2 =
0.129. Every blue dot represents a single protein. Red dotted line = tendency line. (B) Protein abundance of basic components of promastigotes architecture
based on the current gene ontology annotations of cellular component. The values represent the mean of percent of total cellular protein content ± SD (n = 14).
(C) Abundance of ribosomal proteins of the large and small subunits. The values represent the mean of protein copy numbers ± SD (n = 14). (D) Cumulative
abundance of proteins involved in the major energy metabolic processes. Bars show the total sum of the number of copies of proteins involved in each
metabolic pathway ± SD (n = 14).
https://doi.org/10.1371/journal.pntd.0008509.g002
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them are annotated as uncharacterized. Despite that, with the integration of omics data, the
“uncharacterized” universe should represent a rich source of information in the future. Gene
expression levels were analyzed by qPCR for 10 genes encoding for proteins that presented sta-
tistical differences of abundance among at least two species. We observed low correlation
between mRNA levels assessed by qPCR and protein abundance (S4 Fig). This result is not
unexpected since lack of correlation between transcript and protein levels is commonly
observed both in prokaryotes and eukaryotes, including, E. coli, Saccharomyces cerevisiae,
Leishmania spp. and mammalian cells [49–52]. In fact, in Leishmania spp. there is a constitu-
tive expression of most of the genome and gene regulation mainly occurs at posttranscriptional
level by differences on mRNA maturation and stability [53,54]. However, we are aware that
our comparison was limited to 10 genes and we cannot rule out the possibility that deep pair-
wise comparison between transcriptomics and proteomics data could reveal potential correla-
tions among mRNA and protein levels in Leishmania, at least for some genes in the strains
studied here.
To analyze if there were particular groups of proteins that contributed the most for distin-
guishing the L. (Viannia) species, the 185 proteins were submitted to enrichment analysis. The
beta-alanine metabolism (4.00-fold), valine, leucine and isoleucine degradation (3.73-fold) and
fatty acid degradation (3.17-fold) were annotations of metabolic pathways significantly over-
represented. In addition, biological processes including sterol biosynthetic process (15-fold),
sulfur amino acid metabolic process (11.9-fold), monosaccharide metabolic process (6.83-fold)
cellular amino acid metabolic process (3.47-fold), phospholipid biosynthetic process (4.08-fold)
Fig 3. Differences in protein abundance in the proteomes of Leishmania (Viannia) species. (A) Venn diagram shows the number of differentially abundant
proteins among L. braziliensis, L. panamensis and L. guyanensis. (B) Differential protein concentration of diverse isoenzymes used for Leishmania species
identification (n = 5 biological replicates for L. braziliensis and L. panamensis and n = 4 for L. guyanensis). Asterisks denote significant differences in the
proteomics dataset (FDR< 0.01). (C) Principal component analysis of the concentration values of enzymes of the main energy metabolic pathways including
glycolysis, TCA, oxidative phosphorylation, fatty acid beta-oxidation and amino acid oxidation (S4 Table).
https://doi.org/10.1371/journal.pntd.0008509.g003
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and lipid metabolic process (2.49-fold), among others, were also significantly enriched. In gen-
eral, this analysis suggest that the abundance of proteins related to energy metabolism is dis-
tinct between the species here studied.
In order to know whether would have a chromosome that could contribute the most for
those differences in protein abundance, we analyzed the chromosomal localization of the 185
proteins. With the exception of chromosomes 14 and 22, all the other chromosomes contribute
with at least one differentially abundant protein. Interestingly, chromosomes 31, 35, 18 and 16
contributed with most of the differentially abundant proteins (16, 15, 14 and 13 proteins,
respectively) (S5 Fig). Remarkably, proteins coded by genes located on that chromosomes are
mainly transporters, peptidases and uncharacterized integral components of membrane, among
others. Studies on Leishmania ploidy have revealed that chromosome copy number varies sig-
nificantly between species, and even among strains, and that chromosome 31 is supernumer-
ary in all species which ploidy state has been studied to date, including L. braziliensis, L.
guyanensis and L. panamensis [7–16]. The ploidy of the chromosomes 35, 18 and 16 varies
between disomic and trisomic states among different strains of L. braziliensis, L. panamensis
and L. guyanensis [9,12,15,16]. Recently it was reported for L. panamensis that chromosomes
16 and 18 suffered changes in their somy after Sb-resistance selection [15, 16]. Whether the
significant differences in protein abundance observed in our proteome dataset could be reflect-
ing the genetic heterogeneity among those species, resulting from variation in chromosome
number, remains to be clarified. However, the availability of in-depth quantitative protein
data, as the one provided here, is a peremptory condition to answer that question.
Among those proteins that have abundancies significantly different among at least two spe-
cies we identified HSP70, GP63, CPB, RNA pol II, DNA pol, CYB and even several of them
have significantly different concentration among the three L. (Viannia) species studied here
(S4 Table). Various enzymes such as malate dehydrogenase (MDH), isocitrate dehydrogenase
(ICDH), glucose-6-phosphate dehydrogenase (G6PDH), 6-phosphogluconate dehydrogenase
(6PGD) nucleoside hydrolase (NH), glutamate dehydrogenase (GDH), phosphoglucomutase
(PGM), mannose phosphate isomerase (MPI), and glucose-6-phosphate isomerase (GPI) pre-
sented also significant differences in our dataset (S4 Table). All of those molecules are used for
L. (Viannia) species typing using seminal approaches such as multilocus enzyme electrophore-
sis (MLEE) [55,56] or PCR variants including PCR-RFLP and multilocus sequence typing
(MLST) [57–60]. Thus, our proteomics dataset shows that the differences in the abundance of
those proteins between the L. braziliensis, L. guyanensis and L. panamensis strains analyzed
here agree with the molecular polymorphisms commonly observed by MLEE, MLST and/or
PCR-variant analyses. In addition, the depth of our data set allows us to recover the contribu-
tion of many other molecules not previously known for species differentiation.
Leishmania (Viannia) species differ in the abundance of energy metabolism
enzymes
Many of the isoenzymes used as gold standards for Leishmania species identification
[55,56,61] presented significant differential abundance in our proteome dataset (Fig 3B). Since
some of them are essential enzymes of the main energy metabolic pathways we decided to ana-
lyzed if would be possible to differentiate the three species relying only on the titers of enzymes
of the energy metabolic pathways. The “energy profile” based on proteins concentration was
first analyzed by PCA and we clearly observed three distinct clusters, each one corresponding
to each species analyzed here (Fig 3C). Almost 80% of variability is explained by components 1
and 2, showing that there are clear differences in the energy metabolism among species. In
addition, this result also shows that, in terms of energy metabolism, the L. panamensis and L.
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guyanensis strains are more related together compared to the L. braziliensis one. This result is
in agreement with the phylogenetic relationships deduced from different molecular
approaches [55–58].
Further, we specifically compared the abundance of the proteins involved in glycolysis and
oxidative phosphorylation, which are considered as the main metabolic pathways involved in
energy generation in Leishmania promastigotes [20,48]. Remarkably, we observed statistical
differences in the cumulative concentration of proteins involved in the glycolytic pathway
among the species (Fig 4A and S4 Table). Such abundance is significantly higher in L. brazi-
liensis (mean 513 pmol/mg) than in L. panamensis (mean 465 pmol/mg) or L. guyanensis
(mean 473 pmol/mg), reinforcing the idea that these parasites seem to depend differentially on
distinct energy substrates.
Fig 4. Leishmania (Viannia) species significantly differ in the abundance of energy metabolism enzymes. (A) Cumulative concentration of the proteins
involved in glycolysis. Each symbol (dots, squares or triangles) show the total sum of the concentration values of proteins involved in glycolysis in each of the 5
biological replicates for L. braziliensis and L. panamensis or 4 biological replicates for L. guyanensis. Statistical differences by t test (p<0.003 Lb x Lp; p<0.006 Lb x
Lg). (B) 2-NBDG uptake levels. Promastigotes were incubated with 300 μM 2-NBDG, a fluorescent glucose analogue, and further analysed by flow cytometry. Bars
show mean ± SD of at least three independent experiments. Statistical differences by t test (p<0.001). (C) Oxygen consumption under routine conditions (open
bars) or in the presence of 2 μM antimycin A (residual oxygen consumption-ROX, filled bars). ROX control shows a reduction up to 95% in mitochondrial
functionality. Bars show mean and standard deviations of at least three independent experiments. Significant differences by t test. �� p<0.001; ��� p<0.0001. (D)
Concentrations of specific proteins involved in oxidative phosphorylation. Complex I (green background), complex IV (purple background) and complex V (blue
background) enzymes are identified with the UniProt code (S4 Table). Values represent mean ± SD of protein concentration (pmol/mg) [n = 5 biological replicates
for L. braziliensis (dots) and L. panamensis (squares) and n = 4 for L. guyanensis (triangles)]. �Statistical differences according to Perseus analysis (FDR< 0.01) and
further analyzed by the Holm-Sidak method (p<0.01).
https://doi.org/10.1371/journal.pntd.0008509.g004
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This result prompted us to analyze the levels of glucose uptake by each species through the
evaluation of 2-NBDG consumption, a fluorescent glucose analogue [62]. Confirming our pro-
teomics data, L. braziliensis exhibit significant 3.7-fold higher 2-NBDG uptake than L. pana-
mensis (Fig 4B). In addition, this assay revealed that L. guyanensis also uptakes higher levels of
2-NBDG than L. panamensis (2.9-fold). L. guyanensis showed a lower 2-NBDG consumption
level than L. braziliensis, although the difference was not significant (Fig 4B). Conversely, anal-
ysis of mitochondrial O2 consumption showed that L. panamensis strain consumes 2-fold and
2.5-fold more O2 than L. braziliensis and L. guyanensis, respectively (Fig 4C). In agreement
with that results, proteomics data revealed significant differences in the abundance of enzymes
involved in oxidative phosphorylation. Enzymes of the complex I (NADH dehydrogenase),
complex IV (cytochrome c oxidase) and complex V (ATP synthase) exhibited higher concen-
tration in L. panamensis than in the other two species (Fig 4D). In addition, in L. guyanensis
we observed significantly higher titers for complex I and complex IV enzymes compared to L.
braziliensis (Fig 4D). Taking together, our results suggest that L. (Viannia) species differ in the
ways of ATP production. In addition, the analysis of the cumulative concentration of the
enzymes from the other main energy pathways confirmed that both L. guyanensis and L. pana-
mensis rely more on other metabolic pathways such amino acid oxidation and fatty acid beta-
oxidation to obtain ATP than L. braziliensis (S6 Fig). Our results are in good agreement with
early works showing that different Leishmania species consume glucose at different rates and
that glycolysis, mitochondrial respiration and amino acid oxidation are the main ATP sources
for promastigotes, whereas fatty acid beta-oxidation is the main source for amastigotes
[48,63,64]. Further analysis of sugar uptake and oxygen consumption should be performed
over the course of the parasites’ growth curve in order to obtain indisputable data on the meta-
bolic traits of each L. (Viannia) species during parasite differentiation. Although parasites
change their metabolic profile during differentiation from procyclic to metacyclic stages [65,
66], the differences between species observed here are not related with a discrepancy in the
rate of differentiation of parasites because: (i) all replicates of each species were collected at the
same point of the growth curve (late log phase, S3 Fig); (ii) proteins such as SHERP/HASPB
and META1, used as differentiation markers because their abundance increases highly in
metacyclic parasites (stationary phase) [67–70], were not detected in our dataset; (iii) proteins
involved in translation and synthesis of proteins, which are processes very active in organisms
in the log phase (i.e., dividing promastigotes) were highly abundant in our dataset; and (iv) dif-
ferences in the protein abundance of ribosomal subunits, which are decreased in non-dividing
metacyclic parasites (stat phase) [71], were not observed among the species studied here.
Together, our data support the proposition that the three species of L. (Viannia) studied here
have consistent differences in their energy metabolism. Our findings are in agreement with
previous studies on the metabolome of different L. (Leishmania) species that demonstrated
that L. donovani, L. mexicana and L. major are quite distinct in their metabolism [72]. Remark-
ably, large differences in consumption of amino acids were observed between those species
[72]. Thus, potentially, the differences in energy metabolism sources could be a common trait
in Leishmania spp.
Differences on energy metabolism probably reflect the different invertebrate hosts involved
in transmission of each parasite species and their variable feeding sources. Indeed, the geo-
graphical origin of the L. braziliensis strain used here is the Atlantic forest at Brazilian’ Bahia
state where parasites can be transmitted by Lutzomyia whitmani and Lu. intermedia, whereas
L. panamensis comes from the Colombian Andean mountain’s region where the main vector
is Lu. gomezi, and L. guyanensis strain was isolated in the Amazon region where it is mainly
transmitted by Lu. umbratilis [73–75]. Such distinct landscapes exhibit different flora and
fauna for sandflies feeding and those distinct ecological scenarios should influence the
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preference for a particular metabolic pathway in parasites. The study of more strains of each
species will corroborate whether those remarkably differences on energy metabolism are spe-
cies-specific traits.
In addition to the differences in metabolism, we observed that concentration values of
many proteins annotated as integral components of membrane, including transporters, surface
antigens-like proteins, plasma membrane ATPases, and GP63, as well as proteins related to the
metabolism of plasma membrane’ lipids were significantly different across the three L. (Vian-
nia) species (S4 Table, S7 Fig) and allowed distinguishing the three species studied here.
Together, our results reveal a species-specific pattern of protein abundances that might be con-
tributing to specific host adaptation and differentiation. Such remarkable differences could be
exploited for better and suitable diagnosis tools. The mass spectrometry proteomics data have
been deposited to the ProteomeXchange Consortium via the PRIDE [76] partner repository
with the dataset identifier PXD017696.
Conclusions
We provide the first in-depth quantitative proteomic analysis of L. braziliensis, L. panamensis
and L. guyanensis, the etiological agents of cutaneous leishmaniasis in the Americas. Compre-
hensive comparison of the proteomes of strains representing these species allowed us to show
the extension of the differences among those close related species and how such differences
shape specie-specific traits. Our results clearly show that deep quantitative proteomics analysis
is able to distinguish the three species, in a similar way that deep genome sequencing allows
such distinction. Regarding that, we provided information of the total protein content of those
species, their main cellular components, and differences in the abundance of specific proteins
and energy metabolic pathways. Together our results indicate that differences observed at the
major energy metabolic processes, among others, could be contributing for species-specific fit-
ness. Notably, we accomplished that without laborious and expensive protocols for sample
preparation and absolute protein quantification. Indeed, the TPA and proteomic ruler meth-
ods allowed the determination of absolute protein concentrations and copy numbers without
the introduction of peptide or protein modifications. Remarkably, the rich quantitative data
here provided is available for exploring new diagnostic systems that hopefully can be translated
in affordable tools for using in the field.
Supporting information
S1 Fig. Peptide coverage and protein abundance correlation among replicates. (A) 95%
proteins were identified with at least three peptides. Profiles of Pearson’s correlation coefficient
of protein abundance among (B) L. braziliensis replicates, (C) L. panamensis replicates, (D) L.
guyanensis replicates. Plotted values represent the total protein fraction of each individual pro-
tein calculated by the total protein approach.
(TIF)
S2 Fig. Functional annotations of protein identified in L. (Viannia) species proteome. (A)
Number and percentage of proteins in our dataset with any functional annotation for the main
gene ontology (GO) categories of Cellular component, Molecular function and Biological pro-
cess. (B) Number of proteins identified in each one of the main cellular components of Leish-
mania promastigotes, according to GO annotation for cellular component.
(TIF)
S3 Fig. Growth curves of L. braziliensis, L. panamensis and L. guyanensis. Every dot, square
or triangle represents mean ± SD of biological triplicates for L. braziliensis, L. panamensis and
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L. guyanensis, respectively. Growth curves started by adding 1 x 105 parasites/mL in 10 mL of
Schnneider’s medium supplemented with 10% of FBS. Parasites proliferation was evaluated
every 24 h during two weeks by optical microscopy using a hemocytometer.
(TIF)
S4 Fig. Protein abundance and corresponding mRNA levels for 10 selected genes. Values
represent mean ± SD of protein concentration (pmol/mg) [n = 5 biological replicates for L.
braziliensis (dots) and L. panamensis (squares) and n = 4 for L. guyanensis (triangles)]. � Statis-
tical differences according to Perseus analysis (FDR < 0.01). Bars represent mean ± SD of
mRNA relative levels determined by qPCR. � Significant differences by t test.
(TIF)
S5 Fig. Chromosomal localization of differentially abundant proteins among the three spe-
cies.
(TIF)
S6 Fig. Cumulative concentration of the proteins involved in other energy metabolic path-
ways. Bars show the mean of total sum of the concentration values in each species (n = 5 bio-
logical replicates for L. braziliensis and L. panamensis and n = 4 for L. guyanensis). Statistical
differences by t test (p<0.01 Lb x Lb; p<0.005 Lb x Lg; p<0.0001 Lp x Lg).
(TIF)
S7 Fig. Proteins involved in lipids metabolism show significant differences in abundance.
(A) Concentration values of different plasma membrane transporters. (B) Concentration val-
ues of different plasma membrane proteins. (C) Concentration values of proteins involved in
biosynthesis/metabolism of sphingolipid (SL), phospholipid (PL) (green background), iso-
prenoid and sterols (blue background) and other lipids (purple background). Values represent
mean of pmol/mg ± SD (n = 5 biological replicates for L. braziliensis and L. panamensis and
n = 4 for L. guyanensis). All plotted values were statistically different across the three species in
our proteomics dataset (FDR< 0.01) (S4 Table).
(TIF)
S1 Table. Primer sequences used for qPCR amplification.
(XLSX)
S2 Table. Protein groups identification and histone ruler.
(XLSX)
S3 Table. Reproducibility among biological replicates.
(XLSX)
S4 Table. Statistical significance of differences in protein abundance among the species.
(XLSX)
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